In addition, higher BYSL levels were associated with shorter survival times in the TCGA (n = 674, P = 0.018) and CGGA (n = 401, P = 0.31) glioma datasets (Figure 1I, 1J). This evidence concerns the gene BYSL and central nervous system cancer.